Found: 43
Select item for more details and to access through your institution.
Long-term safety and efficacy of lasmiditan for acute treatment of migraine: Final results of the GLADIATOR study.
- Published in:
- Cephalalgia Reports, 2020, v. 3, p. 1, doi. 10.1177/2515816320958176
- By:
- Publication type:
- Article
Treatment patterns of patients diagnosed with major headache disorders: A retrospective claims analysis.
- Published in:
- Cephalalgia Reports, 2020, v. 3, p. 1, doi. 10.1177/2515816320913992
- By:
- Publication type:
- Article
A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraine.
- Published in:
- Neurological Sciences, 2014, v. 35, n. 3, p. 429, doi. 10.1007/s10072-013-1536-0
- By:
- Publication type:
- Article
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.
- Published in:
- Cephalalgia, 2020, v. 40, n. 5, p. 470, doi. 10.1177/0333102419885905
- By:
- Publication type:
- Article
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Botulism associated with Clostridium botulinum sinusitis after intranasal cocaine abuse.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache.
- Published in:
- Journal of Pain Research, 2021, v. 14, p. 2059, doi. 10.2147/JPR.S305066
- By:
- Publication type:
- Article
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Combination of Sumatriptan and Naproxen for Migraine.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Sumatriptan-Naproxen for Acute Treatment of Migraine.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 13, p. 1443, doi. 10.1001/jama.297.13.1443
- By:
- Publication type:
- Article
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine.
- Published in:
- Cephalalgia, 2024, v. 44, n. 4, p. 1, doi. 10.1177/03331024241232944
- By:
- Publication type:
- Article
Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine.
- Published in:
- Cephalalgia, 2022, v. 42, n. 10, p. 1005, doi. 10.1177/03331024221089567
- By:
- Publication type:
- Article
Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies.
- Published in:
- Cephalalgia, 2021, v. 41, n. 14, p. 1458, doi. 10.1177/03331024211028966
- By:
- Publication type:
- Article
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 6, doi. 10.1177/0333102420973994
- By:
- Publication type:
- Article
Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 7, p. 738, doi. 10.1111/head.14767
- By:
- Publication type:
- Article
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 6, p. 730, doi. 10.1111/head.14536
- By:
- Publication type:
- Article
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long‐term clinical trial data.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 3, p. 418, doi. 10.1111/head.14485
- By:
- Publication type:
- Article
A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1164, doi. 10.1111/head.14390
- By:
- Publication type:
- Article
Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 10, p. 2254, doi. 10.1111/head.14011
- By:
- Publication type:
- Article
Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 8, p. 1734, doi. 10.1111/head.13930
- By:
- Publication type:
- Article
Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 3, p. 576, doi. 10.1111/head.13731
- By:
- Publication type:
- Article
Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2016, v. 56, n. 8, p. 1317, doi. 10.1111/head.12896
- By:
- Publication type:
- Article
Early onset of efficacy with erenumab in patients with episodic and chronic migraine.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0923-6
- By:
- Publication type:
- Article
Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1176, doi. 10.1111/cts.12977
- By:
- Publication type:
- Article
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rotigotine improves restless legs syndrome: A 6-month randomized, double-blind, placebo-controlled trial in the United States.
- Published in:
- Movement Disorders, 2010, v. 25, n. 11, p. 1675, doi. 10.1002/mds.23157
- By:
- Publication type:
- Article
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01351-2
- By:
- Publication type:
- Article
Tramadol/Acetaminophen for the Treatment of Acute Migraine Pain: Findings of a Randomized, Placebo-Controlled Trial.
- Published in:
- Headache: The Journal of Head & Face Pain, 2005, v. 45, n. 10, p. 1317, doi. 10.1111/j.1526-4610.2005.00264.x
- By:
- Publication type:
- Article
Valdecoxib for Treatment of a Single, Acute, Moderate to Severe Migraine Headache.
- Published in:
- Headache: The Journal of Head & Face Pain, 2005, v. 45, n. 9, p. 1151, doi. 10.1111/j.1526-4610.2005.00238.x
- By:
- Publication type:
- Article
Intranasal Lidocaine.
- Published in:
- Headache: The Journal of Head & Face Pain, 1995, v. 35, n. 9, p. 565, doi. 10.1111/j.1526-4610.1995.hed3509565_2.x
- By:
- Publication type:
- Article
Rapid and Sustained Relief of Migraine Attacks With Intranasal Lidocaine: Preliminary Findings.
- Published in:
- Headache: The Journal of Head & Face Pain, 1995, v. 35, n. 2, p. 79, doi. 10.1111/j.1526-4610.1995.hed3502079.x
- By:
- Publication type:
- Article
Inheritance of Cluster Headache and its Possible Link to Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 1994, v. 34, n. 7, p. 400, doi. 10.1111/j.1526-4610.1994.hed3407400.x
- By:
- Publication type:
- Article
The Role of Chemoreceptor Activity and Oxyhemoglobin Desaturation in Cluster Headache.
- Published in:
- Headache: The Journal of Head & Face Pain, 1993, v. 33, n. 9, p. 483, doi. 10.1111/j.1526-4610.1993.hed3309483.x
- By:
- Publication type:
- Article
Association of Sustained Oxyhemoglobin Desaturation and Onset of Cluster Headache Attacks.
- Published in:
- Headache: The Journal of Head & Face Pain, 1990, v. 30, n. 8, p. 474, doi. 10.1111/j.1526-4610.1990.hed3008474.x
- By:
- Publication type:
- Article
Successful Aspirin Prophylaxis in a Child with Chronic Paroxysmal Hemicrania.
- Published in:
- Headache: The Journal of Head & Face Pain, 1989, v. 29, n. 5, p. 280, doi. 10.1111/j.1526-4610.1989.hed2905280.x
- By:
- Publication type:
- Article